🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

30 results for “oxytocin” Clear

  1. intranasal oxytocin

    China SXT Pharmaceuticals

    Learning Disabilities

    small molecule active

    1 trial

  2. intranasal oxytocin

    China SXT Pharmaceuticals

    Healthy

    small molecule active

    7 trials

  3. oxytocin

    China SXT Pharmaceuticals

    Interoception

    small molecule completed

    1 trial

  4. oxytocin and misoprostol

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    small molecule completed

    1 trial

  5. oxytocin treatment

    China SXT Pharmaceuticals

    Healthy

    small molecule completed

    1 trial

  6. vasoconstrictor and oxytocin treatment

    China SXT Pharmaceuticals

    Healthy

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources